Bristol-Myers Squibb Company

Stock Chart, Company Information, and Scan Results

$60.62(as of Mar 9, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Bristol-Myers Squibb Company Company Information, Fundamentals, and Technical Indicators

Stock Price$60.62

Ticker SymbolBMY

ExchangeNyse

SectorHealthcare

IndustryDrug Manufacturers - General

Employees32,500

CountyUSA

Market Cap$122,779M

EBIDTA19,116.0M

10-Day Moving Average61.39

20-Day Moving Average60.92

Forward P/E Ratio9.67

50-Day Moving Average57.60

Earnings per Share3.46

200-Day Moving Average49.04

Profit Margin8.69%

RSI54.55

Shares Outstanding2,036.5M

ATR1.37

52-Week High62.89

Volume10,960,118

52-Week Low41.88

Most Recent Support Level60.43

Book Value18,506.0M

Most Recent Resistance Level62.59

Upper Keltner64.00

Lower Keltner57.83

Debt-to-Equity Ratio64.00

Next Earnings Date04/30/2026

Cash Surplus-13,208.0M

Next Ex-Dividend Date04/02/2026

BMY takes the fight against disease to the heart, with leading cardiovascular medications like Camzyos—an FDA-approved treatment for obstructive hypertrophic cardiomyopathy. The global biopharmaceutical company is also well-known for its development of oncology and immunology products, including Opdivo and Yervoy for cancer treatment, and Orencia for rheumatoid arthritis. If you are looking to add a well-diversified biopharmaceutical stock to your portfolio, BMY could be the one.

Bristol-Myers Squibb Company In Our Stock Scanner

As of Mar 09, 2026

example chart graphic

Scan Name: Hammer CandleScan Type: Candlestick Pattern Scans

As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.